CLINICAL RESEARCH: ATHEROSCLEROSIS
Low Levels of Low-Density Lipoprotein Cholesterol and Blood Pressure and Progression of Coronary Atherosclerosis
Adnan K. Chhatriwalla, MD*,
Stephen J. Nicholls, MBBS, PhD*, , ,*,
Thomas H. Wang, MD*,
Kathy Wolski, MPH*,
Ilke Sipahi, MD*,
Tim Crowe, BS*,
Paul Schoenhagen, MD*, ,
Samir Kapadia, MD*,
E. Murat Tuzcu, MD* and
Steven E. Nissen, MD*
* Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio
Department of Cell Biology, Cleveland Clinic, Cleveland, Ohio
Department of Radiology, Cleveland Clinic, Cleveland, Ohio
Center for Cardiovascular Diagnostics and Prevention, Cleveland Clinic, Cleveland, Ohio
Manuscript received July 3, 2008;
revised manuscript received September 16, 2008,
accepted September 22, 2008.
* Reprint requests and correspondence: Dr. Stephen J. Nicholls, Cleveland Clinic, Cardiovascular Medicine, 9500 Euclid Avenue, Mail Code JJ65, Cleveland, Ohio 44195 (Email: nichols1{at}ccf.org).
Objectives: We investigated coronary atheroma progression in patients with low levels of low-density lipoprotein cholesterol (LDL-C) and systolic blood pressure (SBP).
Background: Low LDL-C and SBP beneficially impact coronary atherosclerosis. However, the association between intensive control of both risk factors and coronary plaque progression remains unclear.
Methods: Changes in atheroma burden monitored by intravascular ultrasound were studied in 3,437 patients with coronary artery disease (CAD) who were stratified according to on-treatment LDL-C and SBP.
Results: Patients with very low LDL-C ( 70 mg/dl) and normal SBP ( 120 mm Hg) had less progression in percent atheroma volume (PAV) (p < 0.001) and total atheroma volume (TAV) (p < 0.001), more frequent plaque regression (p = 0.01), and less frequent plaque progression (p < 0.001). In patients with SBP >120 mm Hg, very low LDL-C was associated with less progression of PAV (+0.30%, 95% confidence interval [CI]: –0.17% to 0.77% vs. +0.61%, 95% CI: 0.17% to 1.05%, p = 0.01) and TAV (–3.9 mm3, 95% CI: –7.24 to –0.63 mm3 vs. –1.2 mm3, 95% CI: –4.31 to 1.92 mm3, p = 0.001). In patients with LDL-C >70 mg/dl, normal SBP was not associated with less progression of PAV (+0.51%, 95% CI: 0.04% to 0.99% vs. +0.61%, 95% CI: 0.17% to 1.05%, p = 0.159) or TAV (–2.3 mm3, 95% CI: –5.59 to 1.05 mm3 vs. –1.2 mm3, 95% CI: –4.31 to 1.92 mm3, p = 0.617).
Conclusions: Very low LDL-C and normal SBP are associated with the slowest progression of coronary atherosclerosis. Although a greater beneficial association is observed in patients with very low LDL-C, these findings suggest the need for intensive control of global risk in patients with CAD.
Key Words: coronary artery disease atherosclerosis cholesterol LDL-C hypertension blood pressure intravascular ultrasound
|
Abbreviations and Acronyms
| | BP = blood pressure | | CAD = coronary artery disease | | CI = confidence interval | | IVUS = intravascular ultrasound | | JNC-7 = Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure | | LDL-C = low-density lipoprotein cholesterol | | NCEP = National Cholesterol Education Panel | | PAV = percent atheroma volume | | SBP = systolic blood pressure | | TAV = total atheroma volume |
|
Related Articles
-
Atheroma Volume by Intravascular Ultrasound as a Surrogate for Clinical End Points
- Jonathan M. Tobis and Alice Perlowski
J. Am. Coll. Cardiol. 2009 53: 1116-1118.
[Full Text]
[PDF]
-
Inside This Issue
J. Am. Coll. Cardiol. 2009 53: A24.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
J. M. Tobis and A. Perlowski
Atheroma volume by intravascular ultrasound as a surrogate for clinical end points.
J. Am. Coll. Cardiol.,
March 31, 2009;
53(13):
1116 - 1118.
[Full Text]
[PDF]
|
 |
|
|